← Leaderboards
Calvin Yeang
University Of California, San Diego
$887,760
Attributed
$887,760
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $177.6K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$887,760 · 1
By mechanism
K08$887,760 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Yury Miller$23,938,186
- Katherine Bangen$3,772,126
- Wonkyu Ju$7,383,492
- Zvinka Zoe Zlatar$6,193,197
- Longhou Fang$3,690,250
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectConventional TherapyAgingAortic Valve DisorderAging PopulationApolipoprotein B-100Apolipoprotein Lp(A+)Aortic ValveApolipoproteins BAwardAortic Valve ReplacementBinding SitesBlood VesselsCalcificationCareerCaringCessation Of LifeCharacteristicsCholesterolClinically RelevantClinical TrialsComparativeBindingDesign
Grant awards (5)
Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models$177,552
K08 · FY2024 · HL · contact PI
Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models$177,552
K08 · FY2023 · HL · contact PI
Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models$177,552
K08 · FY2022 · HL · contact PI
Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models$177,552
K08 · FY2021 · HL · contact PI
Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models$177,552
K08 · FY2020 · HL · contact PI